Synthetic cannabinoids induce acute lung inflammation via cannabinoid receptor 1 activation

ERJ Open Res. 2020 Aug 17;6(3):00121-2020. doi: 10.1183/23120541.00121-2020. eCollection 2020 Jul.


Synthetic cannabinoids (SCs) induce a pro-inflammatory condition by activating cannabinoid receptor 1 (CB1R) in the lungs of mice, which raises a potential therapeutic use of CB1R antagonists in SC-induced lung disease resulting in hospitalisation